UBS Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-6,500
Closed -$162K 8901
2014
Q4
$162K Buy
+6,500
New +$153K ﹤0.01% 5244

Other funds holding CURE

UBS Group's CURE Position: Q1 2026 in Review

UBS Group sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q1 2026, closing a stake of 418 shares — an estimated $46.6K sold.

UBS Group first reported a position in CURE in Q1 2015 and held it in 31 quarters. The position peaked at $549K in Q1 2025. 15 funds tracked by Wall St. Rank hold CURE as of Q1 2026.

  • UBS Group reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 418 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2026, an estimated $46.6K.
  • UBS Group first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2015 and held it in 31 quarters.
  • UBS Group's Direxion Daily Healthcare Bull 3X ETF position peaked at $549K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.